Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-03 Sale | 2024-12-03 8:00 pm | Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO | 15,000 | $67 | $1,005,000 | 242,054 (Direct) | View |
| 2024-11-25 Sale | 2024-11-27 8:00 pm | Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO | 25,000 | $51.6 | $1,289,879 | 257,054 (Direct) | View |
| 2024-10-28 Sale | 2024-10-30 7:30 pm | Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO | 25,000 | $53.54 | $1,338,559 | 282,054 (Direct) | View |
| 2024-09-27 Sale | 2024-09-27 7:30 pm | Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO | 25,000 | $46.31 | $1,157,641 | 307,054 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-02 Option Award | 2024-01-03 4:49 pm | N/A 2034-01-01 | Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO | 356,500 | $0 | 356,500 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:30 pm | N/A 2033-01-02 | Janux Therapeutics Inc. | JANX | Campbell David Alan Chief Executive Officer | 310,000 | $0 | 310,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 5:21 pm | N/A 2032-01-02 | Janux Therapeutics Inc. | JANX | Campbell David Alan Chief Executive Officer | 354,250 | $0 | 354,250 (Direct) | View |
Ownership | 2021-06-10 7:02 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Campbell David Alan Chief Executive Officer | 0 | $0 | 2,276,612 (Direct) | View |